Septerna, Inc. Form 8-K Summary
Business Context and Reporting Period
Septerna, Inc. (SEPN), a Delaware corporation, filed this Current Report on Form 8-K on January 12, 2026. The filing serves as a Regulation FD disclosure regarding the company's participation in the 44th Annual J.P. Morgan Healthcare Conference during the week of January 12, 2026.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The document solely references the furnishing of a corporate presentation (Exhibit 99.1) to conference participants.
Guidance, Outlook, and Risks
Management commentary, guidance, and specific risk factors are contained within the attached corporate presentation (Exhibit 99.1). The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Corporate Presentation dated January 2026) for actual financial data, clinical updates, and strategic outlook.
- Note that the presentation materials are not legally "filed" and carry different liability standards than standard SEC filings.
- Verify the company's status as an Emerging Growth Company (indicated as checked in the filing).
- Confirm the trading symbol SEPN on The Nasdaq Stock Market LLC.